Milton, MA – Resident Matt Bergin will run as a member of the Dana-Farber Marathon Challenge team in the 118th Boston Marathon on Monday, April 21.
Bergin is running in honor of a Dana-Farber patient as part of the Dana-Farber Marathon Challenge’s Patient Partner Program, which is a cornerstone of the event. Approximately 50 current and former pediatric cancer patients of Dana-Farber’s Jimmy Fund Clinic are paired with runners in the program, which will enter its 25th year with this running.
The children serve as special motivation for the runners, and, for the young patients and their families, the runners provides a unique and friendly focus outside their illnesses.
Bergin will join more than 700 other program runners from around the world with a goal to raise $5.3 million for cancer research. One hundred percent of the money raised by the Dana-Farber Marathon Challenge team funds Dana-Farber’s Claudia Adams Barr Program in Innovative Basic Cancer Research. The Barr Program supports cornerstone science research in its earliest stages, providing researchers with critical resources to test their leading-edge ideas.
Team members include cancer survivors and patients, and family and friends of those who have been affected by cancer. Runners of all abilities participate with the goal to help put an end to cancer. Team members who receive their entry from Dana-Farber must meet a fundraising commitment of $4,000, and those who obtained their own race entry before joining the team must have a fundraising commitment of $3,500.